130 related articles for article (PubMed ID: 34475238)
1. Cut points identification of continuous biomarkers: A challenge that goes beyond statistical aspects.
Duarte PS
J Nucl Med; 2021 Sep; 62(12):1833. PubMed ID: 34475238
[No Abstract] [Full Text] [Related]
2. Statistical Considerations in the Evaluation of Continuous Biomarkers.
Polley MC; Dignam JJ
J Nucl Med; 2021 May; 62(5):605-611. PubMed ID: 33579807
[TBL] [Abstract][Full Text] [Related]
3. Cut points and contexts.
Busch EL
Cancer; 2021 Dec; 127(23):4348-4355. PubMed ID: 34424538
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to determine two optimal cut-points of a continuous predictor with a U-shaped relationship to hazard ratio in survival data: simulation and application.
Chen Y; Huang J; He X; Gao Y; Mahara G; Lin Z; Zhang J
BMC Med Res Methodol; 2019 May; 19(1):96. PubMed ID: 31072334
[TBL] [Abstract][Full Text] [Related]
5. Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges.
Bartlett JW; Frost C; Mattsson N; Skillbäck T; Blennow K; Zetterberg H; Schott JM
Biomark Med; 2012 Aug; 6(4):391-400. PubMed ID: 22917141
[TBL] [Abstract][Full Text] [Related]
6. A Cooperative Coevolutionary Approach to Discretization-Based Feature Selection for High-Dimensional Data.
Zhou Y; Kang J; Zhang X
Entropy (Basel); 2020 Jun; 22(6):. PubMed ID: 33286385
[TBL] [Abstract][Full Text] [Related]
7. Multivariate Discretization Based on Evolutionary Cut Points Selection for Classification.
Ramírez-Gallego S; García S; Benítez JM; Herrera F
IEEE Trans Cybern; 2016 Mar; 46(3):595-608. PubMed ID: 25794409
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points.
Devanarayan V; Smith WC; Brunelle RL; Seger ME; Krug K; Bowsher RR
AAPS J; 2017 Sep; 19(5):1487-1498. PubMed ID: 28733862
[TBL] [Abstract][Full Text] [Related]
9. Multivariate meta-analysis of prognostic factor studies with multiple cut-points and/or methods of measurement.
Riley RD; Elia EG; Malin G; Hemming K; Price MP
Stat Med; 2015 Jul; 34(17):2481-96. PubMed ID: 25924725
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations.
Erices-Leclercq M; Lubig S; Förster F; Förster R; Baldus S; Rudlowski C; Schröder L
J Cancer Res Clin Oncol; 2022 Feb; 148(2):441-447. PubMed ID: 33991247
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive and comparative review of optimal cut-points selection methods for diseases with multiple ordinal stages.
Hua J; Tian L
J Biopharm Stat; 2020; 30(1):46-68. PubMed ID: 31250693
[TBL] [Abstract][Full Text] [Related]
12. Optimal survival time-related cut-point with censored data.
Liu X; Jin Z
Stat Med; 2015 Feb; 34(3):515-24. PubMed ID: 25382379
[TBL] [Abstract][Full Text] [Related]
13. Patient subgroup identification for clinical drug development.
Huang X; Sun Y; Trow P; Chatterjee S; Chakravartty A; Tian L; Devanarayan V
Stat Med; 2017 Apr; 36(9):1414-1428. PubMed ID: 28147447
[TBL] [Abstract][Full Text] [Related]
14. Calibration and validation of physical behaviour cut-points using wrist-worn ActiGraphs for children and adolescents: A systematic review.
Clanchy K; Stanfield M; Smits E; Liimatainen J; Ritchie C
J Sci Med Sport; 2024 Feb; 27(2):92-104. PubMed ID: 38087661
[TBL] [Abstract][Full Text] [Related]
15. Robustness of [
Palomino-Fernández D; Seiffert AP; Gómez-Grande A; Jiménez López-Guarch C; Moreno G; Bueno H; Gómez EJ; Sánchez-González P
Comput Methods Programs Biomed; 2024 Feb; 244():107981. PubMed ID: 38154326
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers and surrogate end points--the challenge of statistical validation.
Buyse M; Sargent DJ; Grothey A; Matheson A; de Gramont A
Nat Rev Clin Oncol; 2010 Jun; 7(6):309-17. PubMed ID: 20368727
[TBL] [Abstract][Full Text] [Related]
17. Measuring statistical literacy.
Callingham R; Watson JM
J Appl Meas; 2005; 6(1):19-47. PubMed ID: 15701942
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and evaluation of clinical diagnostic scoring system for septic cardiomyopathy].
Shang N; Liu H; Wang N; Li J; Wang Y; Liu L; Guo S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Dec; 33(12):1409-1413. PubMed ID: 35131004
[TBL] [Abstract][Full Text] [Related]
19. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
Paciorek CJ; Liu Y;
Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
[TBL] [Abstract][Full Text] [Related]
20. Developing examinations that use equal raw scores for cut scores.
Swanlund A; Smith E
J Appl Meas; 2010; 11(4):432-42. PubMed ID: 21164230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
